Hutch Humphreys has over 10 years of experience in the pharmaceutical development arena. As the former Director of Regulatory Affairs at Samumed, LLC, in San Diego, CA, he managed multiple development projects from IND to NDA for therapies across several indications. Prior to Samumed, Humphreys was at Amylin Pharmaceuticals and Therapeutics, Inc., both in San Diego, serving in similar regulatory roles for compounds aimed at treating type 2 diabetes and obesity, as well as topical products for use in various dermatological conditions.
Humphreys earned a BS in Chemical Engineering at the University of Kansas. After college, he spent five years as a nuclear-trained submarine officer in the U.S. Navy, serving onboard the USS Helena, homeported in Pearl Harbor, HI and San Diego. Following military service, he attended Keck Graduate Institute, earning a Master of Bioscience degree as part of the second graduating class in 2003.